: Despite its speed, it is often curable with systemic regimens such as R-CHOP or newer targeted therapies like Pola-R-CHP. Market & Epidemiology Insights (2024–2025)
Diffuse Large B-Cell Lymphoma Pipeline Insight - DelveInsight
Comprehensive industry reports and epidemiology forecasts provide the following data for 2024: